Skip to main content
. 2021 Oct 5;12(1):22–26. doi: 10.1016/j.jobcr.2021.09.020

Table 3.

Design T/t group Baseline 1 week % reduction 2 weeks % reduction
Lycopene OP 1.80 ± 0.84 0.80 ± 0.45* 55.56 ± 7.74 0.60 ± 0.55* 66.67 ± 5.75#
Non-OP 1.60 ± 0.55 1.20 ± 0.45* 25.0 ± 3.03 0.80 ± 0.45* 50.0 ± 3.03
Placebo OP 1.60 ± 0.55 0.80 ± 0.45* 50.0 ± 3.03 0.60 ± 0.55* 62.5 ± 2.94
Non-OP 2.00 ± 0.71 1.60 ± 0.55 2.00 ± 1.76 1.80 ± 0.71 10.0 ± 5.76

* Statistically significant (p < 0.05) within the group.

# Statistically significant relative to NOP-placebo (p < 0.001).